Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

mAbs

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Mabs|April 20, 2010
Therapeutic antibodies, vaccines and antibodyomesDimiter S Dimitrov
Mabs|January 5, 2010
Engineered CH2 domains (nanoantibodies)Dimiter S Dimitrov
Mabs|June 29, 2010
Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibodyYang Feng, Xiaodong Xiao, Zhongyu Zhu, et al.
Mabs|January 13, 2010
Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptorMei-Yun Zhang, Yang Feng, Yanping Wang, et al.
Mabs|June 15, 2013
Highly efficient selection of epitope specific antibody through competitive yeast display library sortingVinita Puri, Emily Streaker, Ponraj Prabakaran, et al.
Mabs|December 18, 2014
Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseasesTianlei Ying, Yang Feng, Yanping Wang, et al.
Mabs|January 13, 2010
Identification and characterization of fully human anti-CD22 monoclonal antibodiesXiaodong Xiao, Mitchell Ho, Zhongyu Zhu, et al.
Mabs|December 5, 2019
An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific bindingGuangcan Cao, Xinyu Gao, Yancheng Zhan, et al.
Mabs|January 14, 2010
Americas Antibody Congress: September 21-23, 2009, Washington, D.CSusan E Lacy, Christopher J Bond, Dennis Benjamin, et al.
Mabs|July 17, 2015
Engineered antibody domains with significantly increased transcytosis and half-life in macaques mediated by FcRnTianlei Ying, Yanping Wang, Yang Feng, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Mabs|April 20, 2010
Therapeutic antibodies, vaccines and antibodyomesDimiter S Dimitrov
Mabs|January 5, 2010
Engineered CH2 domains (nanoantibodies)Dimiter S Dimitrov
Mabs|June 29, 2010
Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibodyYang Feng, Xiaodong Xiao, Zhongyu Zhu, et al.
Mabs|January 13, 2010
Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptorMei-Yun Zhang, Yang Feng, Yanping Wang, et al.
Mabs|June 15, 2013
Highly efficient selection of epitope specific antibody through competitive yeast display library sortingVinita Puri, Emily Streaker, Ponraj Prabakaran, et al.
Mabs|December 18, 2014
Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseasesTianlei Ying, Yang Feng, Yanping Wang, et al.
Mabs|January 13, 2010
Identification and characterization of fully human anti-CD22 monoclonal antibodiesXiaodong Xiao, Mitchell Ho, Zhongyu Zhu, et al.
Mabs|December 5, 2019
An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific bindingGuangcan Cao, Xinyu Gao, Yancheng Zhan, et al.
Mabs|January 14, 2010
Americas Antibody Congress: September 21-23, 2009, Washington, D.CSusan E Lacy, Christopher J Bond, Dennis Benjamin, et al.
Mabs|July 17, 2015
Engineered antibody domains with significantly increased transcytosis and half-life in macaques mediated by FcRnTianlei Ying, Yanping Wang, Yang Feng, et al.
Pageof 2